- Home
- CELC vs ASG Comparison
CELC vs ASG Comparison
Compare CELC & ASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- ASG
- Stock Information
- Founded
- CELC 2011
- ASG 1986
- Country
- CELC United States
- ASG United States
- Employees
- CELC N/A
- ASG N/A
- Industry
- CELC Medical Specialities
- ASG Investment Managers
- Sector
- CELC Health Care
- ASG Finance
- Exchange
- CELC Nasdaq
- ASG Nasdaq
- Market Cap
- CELC 391.0M
- ASG 315.2M
- IPO Year
- CELC 2017
- ASG N/A
- Fundamental
- Price
- CELC $10.11
- ASG $4.85
- Analyst Decision
- CELC Strong Buy
- ASG
- Analyst Count
- CELC 6
- ASG 0
- Target Price
- CELC $30.17
- ASG N/A
- AVG Volume (30 Days)
- CELC 248.4K
- ASG 324.3K
- Earning Date
- CELC 03-31-2025
- ASG 01-01-0001
- Dividend Yield
- CELC N/A
- ASG 8.09%
- EPS Growth
- CELC N/A
- ASG N/A
- EPS
- CELC N/A
- ASG N/A
- Revenue
- CELC N/A
- ASG N/A
- Revenue This Year
- CELC $49.98
- ASG N/A
- Revenue Next Year
- CELC N/A
- ASG N/A
- P/E Ratio
- CELC N/A
- ASG N/A
- Revenue Growth
- CELC N/A
- ASG N/A
- 52 Week Low
- CELC $8.53
- ASG $4.47
- 52 Week High
- CELC $22.04
- ASG $5.71
- Technical
- Relative Strength Index (RSI)
- CELC 43.41
- ASG 35.94
- Support Level
- CELC $9.98
- ASG $4.91
- Resistance Level
- CELC $10.70
- ASG $5.12
- Average True Range (ATR)
- CELC 0.68
- ASG 0.09
- MACD
- CELC 0.06
- ASG 0.02
- Stochastic Oscillator
- CELC 28.38
- ASG 19.12
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About ASG Liberty All-Star Growth Fund Inc.
Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.